248
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Endomyometritis after cesarean delivery in the era of antibiotic prophylaxis: incidence and risk factors

, , &
Pages 1214-1219 | Received 17 Nov 2016, Accepted 24 Mar 2017, Published online: 26 Apr 2017

References

  • Burrows LJ, Meyn LA, Weber AM. Maternal morbidity associated with vaginal versus cesarean delivery. Obstet Gynecol. 2004;103:907–912.
  • Chaim W, Bashiri A, Bar-David J, et al. Prevalence and clinical significance of postpartum endometritis and wound infection. Infect Dis Obstet Gynecol. 2000;8:77–82.
  • Declercq E, Barger M, Cabral HJ, et al. Maternal outcomes associated with planned primary cesarean births compared with planned vaginal births. Obstet Gynecol. 2007;109:669–677.
  • ACOG Committee on Practice Bulletins. ACOG Practice Bulletin No. 74. Antibiotic prophylaxis for gynecologic procedures. Obstet Gynecol. 2006;108:225–234.
  • Smaill FM, Grivell RM. Antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section. Cochrane Database Syst Rev. 2014;10:CD007482.
  • Hammad IA, Chauhan SP, Magann EF, Abuhamad AZ. Peripartum complications with cesarean delivery: a review of maternal-fetal medicine units network publications. J Matern Fetal Neonatal Med. 2014;27:463–474.
  • Hamilton BE, Martin JA, Osterman MJ, et al. Births: final data for 2014. Natl Vital Stat Rep. 2015;64:1–64.
  • Olsen MA, Butler AM, Willers DM, et al. Comparison of costs of surgical site infection and endometritis after cesarean delivery using claims and medical record data. Infect Control Hosp Epidemiol. 2010;31:872–875.
  • Perencevich EN, Sands KE, Cosgrove SE, et al. Health and economic impact of surgical site infections diagnosed after hospital discharge. Emerg Infect Dis. 2003;9:196–203.
  • Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap) – a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377–381.
  • ACOG Committee on Obstetric Practice. ACOG Committee Opinion No. 433: optimal goals for anesthesia care in obstetrics. Obstet Gynecol. 2009;113:1197–1199.
  • Tran TS, Jamulitrat S, Chongsuvivatwong V, Geater A. Risk factors for postcesarean surgical site infection. Obstet Gynecol. 2000;95:367–371.
  • Karim H, Chafik K, Karim K, et al. Risk factors for surgical wound infection in digestive surgery. Retrospective study of 3,000 surgical wounds. Tunis Med. 2000;78:634–640.
  • Vamvakas EC, Carven JH. Transfusion of white-cell containing allogeneic blood components and postoperative wound infection: effect of confounding factors. Transfus Med. 1998;8:29–36.
  • Taylor RW, O’Brien J, Trottier SJ, et al. Red blood cell transfusions and nosocomial infections in critically ill patients. Crit Care Med. 2006;34:2302–2308; quiz 2309.
  • Shorr AF, Jackson WL. Transfusion practice and nosocomial infection: assessing the evidence. Curr Opin Crit Care. 2005;11:468–472.
  • Carson JL, Grossman BJ, Kleinman S, et al. Red blood cell transfusion: a clinical practice guideline from the AABB. Ann Intern Med. 2012;157:49–58.
  • Myles TD, Santolaya J. Maternal and neonatal outcomes in patients with a prolonged second stage of labor. Obstet Gynecol. 2003;102:52–58.
  • Piper JM, Bolling DR, Newton ER. The second stage of labor: factors influencing duration. Am J Obstet Gynecol. 1991;165:976–979.
  • Maggio L, Nicolau DP, DaCosta M, et al. Cefazolin prophylaxis in obese women undergoing cesarean delivery: a randomized controlled trial. Obstet Gynecol. 2015;125:1205–1210.
  • Ahmadzia HK, Patel EM, Joshi D, et al. Obstetric surgical site infections: 2 grams compared with 3 grams of cefazolin in morbidly obese women. Obstet Gynecol. 2015;126:708–715.
  • Swank ML, Wing DA, Nicolau DP, McNulty JA. Increased 3-gram cefazolin dosing for cesarean delivery prophylaxis in obese women. Am J Obstet Gynecol. 2015;213:415.e1–8.
  • Bratzler DW, Dellinger EP, Olsen KM, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm. 2013;70:195–283.
  • Oteo J, Aracil B, Alos JI, Gomez-Garces JL. High prevalence of resistance to clindamycin in Bacteroides fragilis group isolates. J Antimicrob Chemother. 2000;45:691–693.
  • Lachiewicz MP, Moulton LJ, Jaiyeoba O. Infection prevention and evaluation of fever after laparoscopic hysterectomy. JSLS. 2015;19:e2015.00065. doi: 10.4293/JSLS.2015.00065
  • Schaumann R, Funke M, Janssen E, Rodloff AC. In vitro activities of clindamycin, imipenem, metronidazole, and piperacillin-tazobactam against susceptible and resistant isolates of Bacteroides fragilis evaluated by kill kinetics. Antimicrob Agents Chemother. 2012;56:3413–3416.
  • Briody VA, Albright CM, Has P, Hughes BL. Use of cefazolin for group B streptococci prophylaxis in women reporting a penicillin allergy without anaphylaxis. Obstet Gynecol. 2016;127:577–583.
  • Rours GI, Duijts L, Moll HA, et al. Chlamydia trachomatis infection during pregnancy associated with preterm delivery: a population-based prospective cohort study. Eur J Epidemiol. 2011;26:493–502.
  • Wager GP, Martin DH, Koutsky L, et al. Puerperal infectious morbidity: relationship to route of delivery and to antepartum chlamydia trachomatis infection. Am J Obstet Gynecol. 1980;138:1028–1033.
  • “2015 Sexually Transmitted Diseases Treatment Guidelines”. Available from: http://www.cdc.gov/std/tg2015/screening-recommendations.htm [last accessed 12 Nov 2016].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.